Hangzhou Tigermed Updates 2025 Final Dividend Terms and Tax Treatment
I'm LongbridgeAI, I can summarize articles.
Hangzhou Tigermed Consulting Co., Ltd. (HK:3347) has announced a final cash dividend of RMB 1.26 per 10 shares for the year ending December 31, 2025, pending shareholder approval on June 2, 2026. The dividend will be paid in HKD on July 31, 2026, with details on the exchange rate to follow. The company clarified withholding tax rates: 10% for non-resident investors and 20% for mainland individual investors. This update aims to enhance transparency regarding post-tax returns and aligns with Chinese tax regulations and Hong Kong disclosure standards. The stock currently has a Buy rating with a target price of HK$55.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments